These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8439591)

  • 1. The in vitro response of human tumour cells to desferrioxamine is growth medium dependent.
    Voest EE; Rooth H; Neijt JP; van Asbeck BS; Marx JJ
    Cell Prolif; 1993 Jan; 26(1):77-88. PubMed ID: 8439591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of desferrioxamine on transferrin receptors, the cell cycle and growth rates of human leukaemic cells.
    Bomford A; Isaac J; Roberts S; Edwards A; Young S; Williams R
    Biochem J; 1986 May; 236(1):243-9. PubMed ID: 3790074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle effects of iron depletion on T-47D human breast cancer cells.
    Reddel RR; Hedley DW; Sutherland RL
    Exp Cell Res; 1985 Dec; 161(2):277-84. PubMed ID: 2998833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of transferrin receptor synthesis by human cytotrophoblast cells in culture.
    Kroos MJ; Starreveld JS; Verrijt CE; van Eijk HG; van Dijk JP
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 65(2):231-4. PubMed ID: 8730630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth of human tumor cell lines in transferrin-free, low-iron medium.
    Neumannova V; Richardson DR; Kriegerbeckova K; Kovar J
    In Vitro Cell Dev Biol Anim; 1995 Sep; 31(8):625-32. PubMed ID: 8528518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine.
    Polson RJ; Jenkins R; Lombard M; Williams AC; Roberts S; Nouri-Aria K; Williams R; Bomford A
    Immunology; 1990 Oct; 71(2):176-81. PubMed ID: 2228020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of growth of the lymphocyte lines by deferoxamine under various iron-supply conditions.
    Kovár J; Seligman P; Gelfand EW
    Folia Biol (Praha); 1993; 39(1):29-39. PubMed ID: 8348983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
    Yang DC; Jiang XP; Elliott RL; Head JF
    Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineoplastic drugs that interfere with iron metabolism in cancer cells.
    Head JF; Wang F; Elliott RL
    Adv Enzyme Regul; 1997; 37():147-69. PubMed ID: 9381969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquisition, storage and release of iron by cultured human hepatoma cells.
    Hirsh M; Konijn AM; Iancu TC
    J Hepatol; 2002 Jan; 36(1):30-8. PubMed ID: 11804661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte lines under iron-depriving conditions: transferrin receptor expression related to various growth responses.
    Kovár J; Seligman P; Gelfand EW
    Immunol Lett; 1994 Oct; 42(3):123-7. PubMed ID: 7890311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.
    Richardson D; Ponka P; Baker E
    Cancer Res; 1994 Feb; 54(3):685-9. PubMed ID: 8306330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reappraisal of the effects of iron and desferrioxamine on the growth of Plasmodium falciparum 'in vitro': the unimportance of serum iron.
    Peto TE; Thompson JL
    Br J Haematol; 1986 Jun; 63(2):273-80. PubMed ID: 3521714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the defect in a variant of HL-60 promyelocytic leukemia cells with reduced transferrin receptor expression.
    Ishiguro K; Ho PT; Sartorelli AC
    Somat Cell Mol Genet; 1992 Jan; 18(1):45-63. PubMed ID: 1546369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of iron and retinoic acid on the control of transferrin receptor and ferritin in the human promonocytic cell line U937.
    Iturralde M; Vass JK; Oria R; Brock JH
    Biochim Biophys Acta; 1992 Feb; 1133(3):241-6. PubMed ID: 1737056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of medium supplemented with insulin-transferrin-selenium for culture of primary bovine calf chondrocytes in three-dimensional hydrogel scaffolds.
    Kisiday JD; Kurz B; DiMicco MA; Grodzinsky AJ
    Tissue Eng; 2005; 11(1-2):141-51. PubMed ID: 15738669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation.
    Bianchi L; Tacchini L; Cairo G
    Nucleic Acids Res; 1999 Nov; 27(21):4223-7. PubMed ID: 10518614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cellular iron concentration on iron uptake by hepatocytes.
    Trinder D; Batey RG; Morgan EH; Baker E
    Am J Physiol; 1990 Oct; 259(4 Pt 1):G611-7. PubMed ID: 2221071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inability of cells to grow in low iron correlates with increasing activity of their iron regulatory protein (IRP).
    Kovár J; Kühn LC; Richardson V; Seiser C; Kriegerbecková K; Musílková J
    In Vitro Cell Dev Biol Anim; 1997 Sep; 33(8):633-9. PubMed ID: 9338146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of transferrin receptor expression by inhibitors of nucleic acid synthesis.
    Hedley D; Rugg C; Musgrove E; Taylor I
    J Cell Physiol; 1985 Jul; 124(1):61-6. PubMed ID: 2413049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.